Why QbD and Digitalization Are Foundations for Cell Therapies
ISPE
NOVEMBER 10, 2022
Modified cells can be tailored to fight what have been considered until now to be untreatable illnesses. His facility gained regulatory approval and supplied the first chimeric antigen receptor T cells (CAR-T) product to young patients with leukemia. When did you first learn about cell therapy and what inspired you to get involved?
Let's personalize your content